Thursday, June 22, 2017 3:19:03 PM
It's a good reminder that the man behind Ronin (Stafford III) is a Monoclonal Ab guy. If you're a PPHM stockholder, you're a Monoclonal Ab guy, too.
I agree that JS III is most likely after a seat at the table. I think he's interested in helping monetize the pipeline and I don't think, frankly, he'll get much opposition from the present BOD. PPHM has advanced enough already that it needs more help.
Many here will disagree with that, but we're moving toward profitability in 12 months, and the game is getting more complex with the forthcoming NCCN trials. PPHM would benefit from his years at Xencor, where he really helped.
It could be a long term play, certainly, but I can't help thinking that even if an RS occurs, some serious move could occur afterwards.
Geo stated that maybe Dart and Stafford could take the company private after the RS. Hadn't thought of that, but it seems remote.
More interesting is Stafford's validation of PPHM science with cold, hard cash. TUTES often can't buy in without a $5 base, so that will come if an RS does occur.
I guess the question is this: let's say you have 49,000 shares of PPHM at 0.58 which = $28240. Post-RS, you have 7,000 shares at 4.06 which = $28240.
But now, the "July Surprise" is announced which drives the pps to $19.47. Now you have $136,290. Three months later, the pps is $37.89, which gives you $265,020. The pre-RS pps would have been $5.40 to give you this same amount. Meaning, we would have completely recovered from the September 2012 Black Monday, even post-RS.
But we're not finished yet. With a nice base in place, the big Pharma boys can go to their stockholders and say, "Look, the PPHM Bavi business triples our responder footprint. We need to finally bite the bullet and buy this company before those bastards at Gilead get into this."
Now remember, outstanding shares are NOT 330 million as they are now. No, they're 47 million. (We're soon profitable, so the ATM runs, but not too much. Make outstanding shares 50 million.) So an offer nicely north of Gilead's Manhasset 12B offer, let's say 19B, appears. OK, under those terms, each share now comes in at $380 flat.
Take the post-RS 7,000 shares mentioned above, and the forlorn post-RS shareholder takes home $2.66M.
In essense, PPHM becomes the new Intercept stock. Why? Because it triples the damn responder anti-PD1 footprint, that's why.
The point remains that if Bavi can make Big Pharma billions more by conditioning the tumor enviroment for anti-XYZers, we have nothing to worry about, whatever may happen in the next 2 weeks.
Best to all, (especially frustrated longs)
Joe Six Pack
Recent CDMO News
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM